Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending April 28, 2006. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding the company's Ordinary Shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory notification of share transactions and does not contain financial performance data.
Material Changes
The filing details a specific transaction on April 25, 2006, where Abacus (GSK) Trustees Limited, acting as trustee for the GlaxoSmithKline Employee Trust, transferred 12,217 Ordinary Shares. These shares were transferred on behalf of participants in the SmithKline Beecham Employee Share Option Plan 1991. The company was advised of these transactions on April 27, 2006.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It notes that the GSK Trust is a discretionary trust where all employees or former employees are potential beneficiaries. Three directors (Dr J-P Garnier, Dr T Yamada, and Mr J S Heslop) are noted as having an interest in the shares held in the trust in the same capacity as other employees.
Investor Verification Points
- Verify the total number of shares transferred (12,217) and the specific date of the transaction (April 25, 2006).
- Confirm the involvement of the SmithKline Beecham Employee Share Option Plan 1991 in this transfer.
- Note that this filing does not impact the company's financial statements or operational metrics.